Quantum-Si shows Proteus data at HUPO 2026 outperforming Platinum Pro
Quantum-Si announced interim results for its Proteus platform at World HUPO 2026, claiming improved performance over its Platinum Pro instrument across several metrics. The Proteus system, still in development, uses a sequencing kit that detects 18 amino acids and aims to advance single-molecule protein sequencing. The company emphasizes that Proteus gear and software are not yet finalized. This explainer outlines what happened, who is affected, and practical next steps.
What changed since Platinum Pro
Quantum-Si presented interim data showing that Proteus outperformed the existing Platinum Pro instrument on multiple measures, including sequencing scale, accuracy, peptide identification, and overall protein sequence coverage. The Proteus setup is described as still in development, with ongoing work on the instrument, consumables, loading protocol, and analysis software. In short, the company says early Proteus results look better across several performance targets, but the system is not yet finalized for commercial release.
Key facts you should know
- Proteus is Quantum-Si’s next-generation platform for protein sequencing, claimed to do single-molecule analysis.
- The interim results compare Proteus to Platinum Pro and report better performance across multiple metrics.
- Data were presented by Quantum-Si’s CEO, Jeff Hawkins, at the World HUPO 2026 conference.
- Proteus and its components (instrument, consumables, loading protocol, software) are described as still in development and not yet fully optimized.
Who is affected
Researchers and laboratories that rely on proteomics and protein sequencing could be affected if Proteus proves to be more capable in final releases. The announcement concerns Quantum-Si’s technology platform and its comparison to its own Platinum Pro instrument. No broad market or consumer implications are stated in the release, and timelines for commercialization remain unspecified.
Practical next steps for readers
- Monitor follow-up data and peer-reviewed validation of Proteus performance once the system is fully developed and publicly documented.
- Watch for updates from Quantum-Si on timelines, availability, and final specifications of Proteus.
- If you’re a researcher or lab manager, plan to review official performance benchmarks and integration requirements before considering any transition from existing platforms.
Limits and questions to consider
The company notes that Proteus software, consumables, and workflow are still under development and not yet optimized. Without independent validation or a finalized product, interested parties should treat interim results as promotional disclosures rather than conclusive performance evidence. No cost, availability, or regulatory details are provided in the source.
Which sources did Setup in Bahrain review?
Setup in Bahrain reviewed the following source material before preparing this explanatory article.
The links remain visible so readers can inspect the evidence, compare dates and context, and confirm current requirements with the relevant authority.
- investingnews.com — evidence source reviewed for this article.
Information and responsibility notice: This article is general information based on the cited material available when published. It is not legal, tax, immigration, medical, financial, banking, or investment advice; it does not create a professional-client relationship; and it is not a guarantee of outcome, availability, accuracy, or eligibility. Rules, schedules, prices, and third-party information can change. Confirm material decisions with the relevant authority and an appropriately qualified adviser before acting.
